asa glp 1 agonist guidelines Aspiration risk and strategic approach for patients receiving GLP-1 receptor agonists undergoing elective surgery aGLP-1 receptor agonists & anesthesia:

We used version 2 of the Cochrane risk-of-bias tool for randomised trials to assess risk of bias for the primary outcome

In the last 20 years, the emergence of pharmacological treatments for obesity based on gastrointestinal hormones has transformed the ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, ...

Clinically backed oral GLP-1 support with a 321% natural GLP-1 boost

There 9 types of antidiabetic drugs, of which GLP-1RAs are the most popular, find the evolution of GLP-1RAs and their challenges and solutions,

Further studies are needed to assess the potential cardiovascular and renal benefits of combination therapy and to determine suitable patient population for the therapy